KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Home  /  About the Reporter  /  Park Pyeongtak
박병탁 기자

Park Pyeongtak

Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail ppt@kormedi.com

Latest Articles

Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

4/7/2026

Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

4/1/2026

Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

3/30/2026

Daewoong Pharmaceutical to Distribute 'The Spirokit' Digital Pulmonary Function Tester

3/27/2026

Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan

3/24/2026

Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June

3/24/2026

Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

3/17/2026

Daewoong Pharmaceutical: Early Arrhythmia Detection Through Wearable ‘MobiCare’ Device

3/13/2026
123Next
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 7th floor, Seongwoo Building, 324 Toegye-ro, Jung-gu, Seoul
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All rights reserved.powered by Pango Lingo
Languages

ENGLISH

English (US)

ASIAN

日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية